Articles published by ADMA Biologics, Inc.
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces CFO Transition
February 28, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 28, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 21, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
January 08, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 18, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 16, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
February 08, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
December 13, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
![](https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg)
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers
ADMA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.